These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12586581)

  • 1. Sterilization issues in vCJD: significance for prophylaxis.
    Dealler S
    J Hosp Infect; 2003 Feb; 53(2):155-6. PubMed ID: 12586581
    [No Abstract]   [Full Text] [Related]  

  • 2. Sterilization issues in vCJD--towards a consensus: meeting between the Central Sterilizing Club and Hospital Infection Society. 12th September 2000.
    Spencer RC; Ridgway GL;
    J Hosp Infect; 2002 Jul; 51(3):168-74. PubMed ID: 12211182
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inactivation and removal of prions in producing medical products. A contribution to evaluation and declaration of possible methods].
    Bertram J; Mielke M; Beekes M; Lemmer K; Baier M; Pauli G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Jan; 47(1):36-40. PubMed ID: 15205822
    [No Abstract]   [Full Text] [Related]  

  • 4. Hostile world.
    Shimkus J
    Mater Manag Health Care; 1998 Feb; 7(2):24-5, 27. PubMed ID: 10180778
    [No Abstract]   [Full Text] [Related]  

  • 5. Product Study. Disposing of the CJD threat.
    Cys J
    Mater Manag Health Care; 2002 Feb; 11(2):27. PubMed ID: 11922034
    [No Abstract]   [Full Text] [Related]  

  • 6. New prion inactivation treatment presented.
    Health Estate; 2007 Jun; 61(6):52-3. PubMed ID: 17724956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variant Creutzfeldt-Jakob disease (vCJD). Precautionary measures against the risk of transmission of the agent of vCJD by blood transfusion.
    Wkly Epidemiol Rec; 2000 Nov; 75(47):377-9. PubMed ID: 11144617
    [No Abstract]   [Full Text] [Related]  

  • 8. Autoclaving standards for Creutzfeldt-Jakob disease agent.
    Taylor DM
    Ann Neurol; 1987 Oct; 22(4):557-8. PubMed ID: 3124711
    [No Abstract]   [Full Text] [Related]  

  • 9. Precautions in handling tissues, fluids, and other contaminated materials from patients with documented or suspected Creutzfeldt-Jakob disease. Committee on Health Care Issues, American Neurological Association.
    Ann Neurol; 1986 Jan; 19(1):75-7. PubMed ID: 3511838
    [No Abstract]   [Full Text] [Related]  

  • 10. 'Mad cow' particle challenges infection control.
    OR Manager; 1996 Jul; 12(7):18-9. PubMed ID: 10158526
    [No Abstract]   [Full Text] [Related]  

  • 11. [Decontamination and sterilization of surgical instruments in suspected Creutzfeldt-Jakob disease. Are we converting to the recommendations by the Robert Koch Institute?].
    Tropitzsch A; Zenner HP
    HNO; 2004 Oct; 52(10):871-4. PubMed ID: 15309323
    [No Abstract]   [Full Text] [Related]  

  • 12. Handling of surgical instruments in a presymptomatic familial carrier of Creutzfeldt-Jakob disease.
    Fishman M; Fort GG; Mikolich DJ
    Am J Infect Control; 2002 Aug; 30(5):303-6. PubMed ID: 12163865
    [No Abstract]   [Full Text] [Related]  

  • 13. Dental Instrument Sterilization and Creutzfeldt-Jakob Disease.
    Martin AP
    Aust Endod J; 2007 Dec; 33(3):143-4. PubMed ID: 18076584
    [No Abstract]   [Full Text] [Related]  

  • 14. Limited efficacy of steam sterilization to inactivate vCJD infectivity.
    Fernie K; Hamilton S; Somerville RA
    J Hosp Infect; 2012 Jan; 80(1):46-51. PubMed ID: 22099953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guideline for disinfection and sterilization of prion-contaminated medical instruments.
    Rutala WA; Weber DJ;
    Infect Control Hosp Epidemiol; 2010 Feb; 31(2):107-17. PubMed ID: 20055640
    [No Abstract]   [Full Text] [Related]  

  • 16. Variant Creutzfeldt-Jakob disease and prions in the blood supply.
    Rohwer RG; Drohan W
    Clin Adv Hematol Oncol; 2004 Feb; 2(2):84, 87, 131. PubMed ID: 16163166
    [No Abstract]   [Full Text] [Related]  

  • 17. Iatrogenic vCJD from surgical instruments.
    Frosh A; Joyce R; Johnson A
    BMJ; 2001 Jun; 322(7302):1558-9. PubMed ID: 11431283
    [No Abstract]   [Full Text] [Related]  

  • 18. Transfusion transmission of vCJD: a crisis avoided?
    Wilson K; Ricketts MN
    Lancet; 2004 Aug 7-13; 364(9433):477-9. PubMed ID: 15302172
    [No Abstract]   [Full Text] [Related]  

  • 19. Additional precautions to prevent transmission of Creutzfeldt-Jakob disease and other prion diseases.
    Woods R
    FDI World; 1997; 6(1):11-6. PubMed ID: 9552651
    [No Abstract]   [Full Text] [Related]  

  • 20. Production cell substrates and vCJD.
    Minor RD; Cooper J
    Dev Biol (Basel); 2006; 123():325-33; discussion 349-54. PubMed ID: 16566456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.